0001921094-23-000485.txt : 20230814 0001921094-23-000485.hdr.sgml : 20230814 20230814144439 ACCESSION NUMBER: 0001921094-23-000485 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Denali Therapeutics Inc. CENTRAL INDEX KEY: 0001714899 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463872213 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38311 FILM NUMBER: 231168805 BUSINESS ADDRESS: STREET 1: 161 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 866-8548 MAIL ADDRESS: STREET 1: 161 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Ho Carole CENTRAL INDEX KEY: 0001724605 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O DENALI THERAPEUTICS INC. STREET 2: 151 OYSTER POINT BLVD., 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 144 1 primary_doc.xml 144 0001724605 XXXXXXXX LIVE 0001714899 Denali Therapeutics Inc. 001-38311 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548 Ho Carole Officer Common Charles Schwab & Co., Inc.

3000 Schwab Way Westlake TX 76262

2768 65850.00 137422131 08/14/2023 NASDAQ Common 08/09/2023 Restricted Stock Lapse Denali Therapeutics Inc. N 2768 08/09/2023 Equity Compensation N Carole Ho

161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080

Denali Therapeutics Inc. 08/10/2023 2857 68983.00 Shares sold in ROHATGI-HO FAMILY 2009 REVOCABLE TRUST. 08/14/2023 03/30/2023 Carole Ho TTEE